Matt v. Northwestern Mutual Life Insurance Co

CourtDistrict Court, W.D. Louisiana
DecidedJanuary 20, 2022
Docket6:20-cv-00829
StatusUnknown

This text of Matt v. Northwestern Mutual Life Insurance Co (Matt v. Northwestern Mutual Life Insurance Co) is published on Counsel Stack Legal Research, covering District Court, W.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Matt v. Northwestern Mutual Life Insurance Co, (W.D. La. 2022).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION

JASON ANTHONY MATT CASE NO. 6:20-CV-00829

VERSUS JUDGE JAMES D. CAIN, JR.

NORTHWESTERN MUTUAL LIFE MAGISTRATE JUDGE CAROL B. INSURANCE CO WHITEHURST

MEMORANDUM RULING

Before the court are cross-motions for summary judgment [docs. 21, 22], filed on the issue of the decedent’s coverage under a life insurance policy issued by the defendant. Both motions are opposed. The matter came for hearing before the undersigned on January 18, 2022, and the court now issues this ruling. I. BACKGROUND

This dispute arises defendant Northwestern Mutual Life Insurance Company’s efforts to cancel coverage under a term life insurance policy after discovering alleged material misrepresentations by the decedent, Steven Matt, on his application. Matt executed an “Individual Life Insurance Application” on May 8, 2017, and completed and executed the second part of the application, the “Medical History Questionnaire” (“MHQ”), the following day after meeting with a paramedical examiner. Doc. 22, atts. 4 & 5. He also executed an “Authorization for Release of Health Information.” Doc. 22, att. 9. Based on these forms and information received from the examiner, the decedent was approved for coverage at the premier classification rate and issued a life insurance policy in the amount of $350,000, effective May 1, 2017. Doc. 22, atts. 10 & 11. The decedent received a copy of the policy. See doc. 22, att. 12 (policy delivery

acknowledgment, executed on May 30, 2017). Under § 1.4 Incontestability, the policy states that the company has relied on the application in issuing the policy and may contest the policy if it has been in force for less than two years during the lifetime of the insured.1 Doc. 22, att. 11, p. 9. During this period, the company may rescind insurance or deny a claim “on the basis of a material misstatement in the application(s)[.]” Id.

The decedent died by suicide on or about April 15, 2019, in Lafayette, Louisiana. Doc. 21, att. 4, p. 5. Shortly thereafter Northwestern was informed of his death. Doc. 22, att. 3, ¶ 13. The beneficiary of the policy at the time was a trust designated under the will of the insured, for the benefit of his two minor children. Doc. 22, att. 13. Northwestern employee Jason Rudelich sent a letter to Jason Matt, the trustee and plaintiff in this matter,

on April 22, 2019. Doc. 22, att. 14. Rudelich informed plaintiff that, because the policy was less than two years old, Northwestern would be conducting a review to confirm that the information provided in the application was complete and accurate. Id. He also enclosed forms and authorizations related to the claim and review process. Id. Relevant to this matter, the decedent answered “No” to the following questions on

his MHQ (completed on May 9, 2017): (1) if he had used tobacco or nicotine products, including smoking cessations products, in the last five years, (2) if he had ever sought,

1 Outside of this period, the company reserves the right to contest coverage in cases of fraud. See id. received, or been advised to seek treatment or counseling for use of alcohol or drugs, (3) if he had otherwise consulted a healthcare provider in the last five years, (4) if he had otherwise been a patient in a hospital, clinic, rehabilitation center, or medical facility in the

last five years, and (5) if he was taking any medications other than what he had already disclosed. Doc. 22, att. 5. He answered “Yes” to a question asking if he had been diagnosed with or treated for “[a]nxiety, depression, stress, bipolar disorder, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), eating disorders or any other psychiatric or mental health disease or disorder” in the last ten years. Id. In the

space to explain his answer, he only provided details relating to an ADHD diagnosis, for which he took Vyvanse, and treatment with one provider, Dr. Boris Rubashkin. Id. Based on his review, however, Rudelich uncovered a significant and recent history of mental health treatment on the part of the decedent. He learned through a social media investigation that the decedent, who had completed the application as a resident of

Lafayette, Louisiana, had also lived in Houston, Texas, at times prior to and after the issuance of the policy. Doc. 22, att. 3, ¶ 16. Using the decedent’s Houston ZIP code, Rudelich discovered that the decedent had been treated by multiple undisclosed providers between July 2016 and May 2017, and filled prescriptions during this period for lithium carbonate (a drug for the treatment of bipolar disorder) and the antipsychotics aripiprazole

and quetiapine fumarate. Id. at ¶¶ 16–20; doc. 22, att. 17. The decedent first saw Dr. Chad Manuel on May 2, 2017, one week before he completed his life insurance application. Doc. 22, att. 19. At that appointment he stated that he had been diagnosed as bipolar.2 Id. at 4. Records from Dr. Boris Rubashkin, the only provider disclosed in the MHQ, indicated that, as of September 2016, the decedent used tobacco products every day. Doc. 22, att. 20, p. 4. In those records the decedent also

referenced a hospitalization in August 2016 for depression and an adolescent history of drug use. Id. at 8. Dr. Rubashkin, who last saw the decedent in December 2016, listed his diagnoses as major depressive disorder, adjustment disorder, anxiety disorder, and ADHD. Id. at 3. Finally, Northwestern obtained records from Dr. Richard Broussard, who saw the decedent in January 2018 and recorded his history of bipolar disorder.3 Doc. 22, att. 21.

This information was reviewed by underwriter Tim Labecki, who provided a memorandum outlining the impact the inconsistencies between the above information and what was provided during the underwriting process. Doc. 22, att. 22. He noted that Northwestern was still awaiting records from two other physicians who had prescribed medications to the decedent. Id. Labecki stated, however, that the existing records were

sufficient to show misrepresentations on the decedent’s tobacco usage and mental health history. He concluded that the tobacco history would have required the policy be issued at tobacco rates and that “[g]iven the severity of the [mental health] symptoms prior to and around the time of the application, we would not have issued this policy.” Id. at 3.

2 At the visit on May 2, 2017, the decedent told Dr. Manuel that he was not currently taking lithium. Doc. 22, att. 19, p. 4. Dr. Manuel prescribed lithium, quetiapine, aripiprazole, hydroxyzine, as well as medications (Vyvanse and Adderall) for his ADHD. Id. at 3. 3 Dr. Broussard saw the decedent in January 2018 for evaluation of blood in stool. Doc. 22, att. 21. The decedent had informed Dr. Broussard that the symptoms began a year ago, though as Northwestern points out, he answered on his MHQ that he had not “been told [he] had, been diagnosed with, or been treated for” any of several conditions, including blood in the stool, over the last ten years. Id.; doc. 22, att. 5. There is no indication that the decedent sought medical attention for his symptoms prior to May 2017, or was told he should do so. Accordingly, the court will not evaluate this response as part of the decedent’s alleged misrepresentations. On October 24, 2019, Rudelich sent plaintiff a letter outlining the results of the contestability review and informing him of Northwestern’s decision to rescind the policy and refund the decedent’s premiums. Doc. 22, att. 23. The plaintiff filed suit against

Northwestern in Louisiana state court in his capacity of trustee, alleging breach of the life insurance contract and bad faith failure to pay. Doc. 1, att. 1. Northwestern then removed the matter to this court on the basis of diversity jurisdiction, 28 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Tubacex, Inc. v. M/V Risan
45 F.3d 951 (Fifth Circuit, 1995)
Guillory v. Domtar Industries Inc.
95 F.3d 1320 (Fifth Circuit, 1996)
Malacara v. Garber
353 F.3d 393 (Fifth Circuit, 2003)
Brumfield v. Hollins
551 F.3d 322 (Fifth Circuit, 2008)
Erie Railroad v. Tompkins
304 U.S. 64 (Supreme Court, 1938)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Reeves v. Sanderson Plumbing Products, Inc.
530 U.S. 133 (Supreme Court, 2000)
State Farm Mutual Automobile Insurance Co. v. Bridges
36 So. 3d 1142 (Louisiana Court of Appeal, 2010)
Abshire v. Desmoreaux
970 So. 2d 1188 (Louisiana Court of Appeal, 2007)
Cates v. Sears, Roebuck & Co.
928 F.2d 679 (Fifth Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
Matt v. Northwestern Mutual Life Insurance Co, Counsel Stack Legal Research, https://law.counselstack.com/opinion/matt-v-northwestern-mutual-life-insurance-co-lawd-2022.